Yongsoo Kim Selected Research

Yongsoo Kim Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 09/2002
7	Breast Neoplasms (Breast Cancer) 10/2019 - 01/2016
4	Fibrosis (Cirrhosis) 07/2020 - 10/2014
3	Liver Diseases (Liver Disease) 07/2020 - 10/2014
3	Portal Hypertension 01/2020 - 11/2015
3	Hepatocellular Carcinoma (Hepatoma) 03/2015 - 09/2006
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 11/2018
2	Varicose Veins (Varicose Vein) 01/2020 - 02/2013
2	Carcinoma (Carcinomatosis) 06/2019 - 11/2018
2	Infections 06/2019 - 02/2011
2	Endometrial Neoplasms (Endometrial Cancer) 01/2017 - 01/2016
2	Rheumatoid Arthritis 01/2017 - 09/2015
2	Splenomegaly 01/2016 - 07/2015
2	Liver Cirrhosis (Hepatic Cirrhosis) 09/2015 - 10/2014
2	Interstitial Cystitis (Interstitial Cystitis, Chronic) 12/2012 - 06/2011
1	Pain (Aches) 01/2022
1	Weight Loss (Weight Reduction) 03/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Weight Gain 11/2020
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 06/2019
1	Wounds and Injuries (Trauma) 06/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2018
1	Velopharyngeal Insufficiency 12/2018
1	Articulation Disorders (Speech Articulation Disorder) 12/2018
1	Mesothelioma 01/2018
1	Atherosclerosis 01/2018
1	Insulin Resistance 08/2017
1	Non-alcoholic Fatty Liver Disease 08/2017
1	Ascites 11/2015
1	Leukemia 08/2015
1	Mouth Neoplasms (Oral Cancer) 08/2015
1	Reperfusion Injury 01/2014
1	Vascular Calcification 03/2013
1	Brain Injuries (Brain Injury) 07/2011
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2011
1	Inflammation (Inflammations) 06/2011

Drug/Important Bio-Agent (IBA)

5	Transcription Factors (Transcription Factor)IBA 10/2019 - 01/2016
4	Pharmaceutical PreparationsIBA 01/2022 - 08/2017
4	ChromatinIBA 10/2019 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 06/2016 - 12/2012
3	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2018
3	4-(3-chlorophenylsulfanyl)piperidineIBA 01/2020 - 11/2015
3	Histones (Histone)IBA 11/2018 - 01/2016
3	Estrogen Receptor alphaIBA 01/2018 - 01/2016
3	Tamoxifen FDA LinkGeneric 01/2017 - 01/2016
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2020 - 08/2017
2	Estrogen ReceptorsIBA 10/2019 - 01/2017
2	Alanine Transaminase (SGPT)IBA 08/2017 - 07/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 06/2016
2	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 09/2015
1	AndrogensIBA 01/2022
1	enzalutamideIBA 01/2022
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2022
1	EmulsionsIBA 03/2021
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2021
1	Peptide Elongation Factor 2 (EF-2)IBA 11/2020
1	Biological ProductsIBA 11/2019
1	GATA3 Transcription FactorIBA 01/2019
1	histone H3 trimethyl Lys4IBA 11/2018
1	Phenobarbital (Luminal)FDA Link 11/2018
1	RNA (Ribonucleic Acid)IBA 11/2018
1	LigandsIBA 11/2018
1	Hormones (Hormone)IBA 01/2018
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2018
1	SteroidsIBA 01/2018
1	Succinic Acid (Succinate)IBA 01/2018
1	TabletsIBA 08/2017
1	CholesterolIBA 08/2017
1	Triglycerides (Triacylglycerol)IBA 08/2017
1	Nonesterified Fatty Acids (NEFA)IBA 08/2017
1	Estrogens (Estrogen)FDA Link 01/2017
1	Lysine (L-Lysine)FDA Link 01/2017
1	SDMIBA 01/2017
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2016
1	Caspase 3 (Caspase-3)IBA 08/2015
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2015
1	evodiamineIBA 08/2015
1	SeleniumIBA 01/2014
1	AntioxidantsIBA 01/2014
1	IodineIBA 04/2013
1	gadolinium ethoxybenzyl DTPA FDA Link 03/2013
1	Galectin 3 (LGALS3)IBA 07/2011
1	IsotopesIBA 06/2011
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2011
1	Amino Acids FDA Link 06/2011
1	SialoglycoproteinsIBA 06/2011
1	Proteins (Proteins, Gene)FDA Link 06/2011
1	CateninsIBA 06/2011
1	histidine-rich proteinsIBA 02/2011
1	PrionsIBA 02/2011
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2006
1	Capsules (Microcapsules)IBA 09/2006
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2006

Therapy/Procedure

4	Therapeutics 01/2022 - 06/2016
3	Radiofrequency Ablation 03/2015 - 05/2005
1	Radiotherapy 06/2019
1	Language Therapy (Language Training) 12/2018
1	Renal Dialysis (Hemodialysis) 03/2013
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 02/2013